title: A series of novel, highly potent and selective agonists for the kappa-opioid receptor.
abstract: 1. This paper describes the opioid receptor pharmacology and in vivo activity of several novel benzene-acetamidopiperidine and benzeneacetamidopiperazine analogues. 2. These compounds all showed potent, naloxone-reversible, full agonist activity in the field-stimulated rabbit vas deferens, indicating that they are kappa-opioid agonists; but showed very little activity in the rat or hamster vas deferens, indicating good selectivity with regard to mu- and delta-opioid receptors. 3. They were all potent antinociceptive agents, the most potent compound, GR 103545, having an ED50 value in the mouse abdominal constriction test of 0.25 micrograms kg-1 s.c. The compounds also produced sedation and diuresis, but had little effect on respiration rate or gastrointestinal motility. 4. It is concluded that the seven novel compounds described are all potent and selective agonists for the kappa-opioid receptor.
authors.affiliation: Department of Neuropharmacology, Glaxo Group Research Ltd., Ware. Herts.
authors.forename: A G
authors.initials: AG
authors.lastname: Hayes
authors.forename: P J
authors.initials: PJ
authors.lastname: Birch
authors.forename: N J
authors.initials: NJ
authors.lastname: Hayward
authors.forename: M J
authors.initials: MJ
authors.lastname: Sheehan
authors.forename: H
authors.initials: H
authors.lastname: Rogers
authors.forename: M B
authors.initials: MB
authors.lastname: Tyers
authors.forename: D B
authors.initials: DB
authors.lastname: Judd
authors.forename: D I
authors.initials: DI
authors.lastname: Scopes
authors.forename: A
authors.initials: A
authors.lastname: Naylor
mesh_terms: D000005:Abdomen / Q000502:physiology; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D044482:Benzeneacetamides; D006224:Cricetinae; D004558:Electric Stimulation; D066298:In Vitro Techniques; D008297:Male; D008647:Mesocricetus; D051379:Mice; D008815:Mice, Inbred Strains; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D011957:Receptors, Opioid / Q000187:drug effects*; D017473:Receptors, Opioid, kappa; D014554:Urination / Q000187:drug effects; D014649:Vas Deferens / Q000187:drug effects
chemical_list: D000700:Analgesics; D044482:Benzeneacetamides; D009292:Narcotic Antagonists; D011759:Pyrrolidines; D011957:Receptors, Opioid; D017473:Receptors, Opioid, kappa; D009270:Naloxone; C045444:U 69593